CME Group Stock Rises After Citigroup Upgrade, JPMorgan Price Target Boost
MT Newswires Live
Sep 26
CME Group (CME) shares rose 1.9% in recent Thursday trading after Citigroup upgraded the stock to buy from neutral and raised its price target to $300 from $275.
JPMorgan also raised its price target on CME to $252 from $246 and kept its underweight rating.
Intraday volume topped 1.55 million shares, compared with the daily average of almost 2.01 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.